 | • レポートコード：GIR-107A12236 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、変形性関節症疼痛治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。変形性関節症疼痛治療薬の種類別市場規模（経口、注射、外部）、用途別市場規模（医療、パーソナルケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・変形性関節症疼痛治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、注射、外部 ・用途別分析2016年-2026年：医療、パーソナルケア ・変形性関節症疼痛治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・変形性関節症疼痛治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・変形性関節症疼痛治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・変形性関節症疼痛治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・変形性関節症疼痛治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Drugs for Osteoarthritis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Drugs for Osteoarthritis Pain size is estimated to be USD 11190 million in 2026 from USD 8983.1 million in 2020, with a change XX% between 2020 and 2021. The global Drugs for Osteoarthritis Pain market size is expected to grow at a CAGR of 5.6% for the next five years.
Market segmentation
Drugs for Osteoarthritis Pain market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral
Injection
External
Market segment by Application, can be divided into
Medical Care
Personal Care
Market segment by players, this report covers
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Drugs for Osteoarthritis Pain product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Drugs for Osteoarthritis Pain, with revenue, gross margin and global market share of Drugs for Osteoarthritis Pain from 2019 to 2021.
Chapter 3, the Drugs for Osteoarthritis Pain competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Drugs for Osteoarthritis Pain market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Drugs for Osteoarthritis Pain research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Drugs for Osteoarthritis Pain
1.2 Classification of Drugs for Osteoarthritis Pain by Type
1.2.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Injection
1.2.5 External
1.3 Global Drugs for Osteoarthritis Pain Market by Application
1.3.1 Overview: Global Drugs for Osteoarthritis Pain Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Drugs for Osteoarthritis Pain Market Size & Forecast
1.5 Global Drugs for Osteoarthritis Pain Market Size and Forecast by Region
1.5.1 Global Drugs for Osteoarthritis Pain Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Drugs for Osteoarthritis Pain Market Size by Region, (2016-2021)
1.5.3 North America Drugs for Osteoarthritis Pain Market Size and Prospect (2016-2026)
1.5.4 Europe Drugs for Osteoarthritis Pain Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Drugs for Osteoarthritis Pain Market Size and Prospect (2016-2026)
1.5.6 South America Drugs for Osteoarthritis Pain Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Drugs for Osteoarthritis Pain Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Drugs for Osteoarthritis Pain Market Drivers
1.6.2 Drugs for Osteoarthritis Pain Market Restraints
1.6.3 Drugs for Osteoarthritis Pain Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Drugs for Osteoarthritis Pain Product and Solutions
2.1.4 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions
2.2.4 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions
2.3.4 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 GlaxoSmithKline Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Drugs for Osteoarthritis Pain Product and Solutions
2.4.4 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions
2.5.4 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Drugs for Osteoarthritis Pain Product and Solutions
2.6.4 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Drugs for Osteoarthritis Pain Product and Solutions
2.7.4 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Sanofi Recent Developments and Future Plans
2.8 Horizon Pharma
2.8.1 Horizon Pharma Details
2.8.2 Horizon Pharma Major Business
2.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions
2.8.4 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Horizon Pharma Recent Developments and Future Plans
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Drugs for Osteoarthritis Pain Product and Solutions
2.9.4 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Abbott Recent Developments and Future Plans
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Drugs for Osteoarthritis Pain Product and Solutions
2.10.4 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Mylan Recent Developments and Future Plans
2.11 Daiichi Sankyo
2.11.1 Daiichi Sankyo Details
2.11.2 Daiichi Sankyo Major Business
2.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions
2.11.4 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Daiichi Sankyo Recent Developments and Future Plans
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Drugs for Osteoarthritis Pain Product and Solutions
2.12.4 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 TEVA Recent Developments and Future Plans
2.13 Almatica Pharma
2.13.1 Almatica Pharma Details
2.13.2 Almatica Pharma Major Business
2.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions
2.13.4 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Almatica Pharma Recent Developments and Future Plans
2.14 Astellas Pharma
2.14.1 Astellas Pharma Details
2.14.2 Astellas Pharma Major Business
2.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions
2.14.4 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Astellas Pharma Recent Developments and Future Plans
2.15 Tide Pharmaceutical
2.15.1 Tide Pharmaceutical Details
2.15.2 Tide Pharmaceutical Major Business
2.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
2.15.4 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Tide Pharmaceutical Recent Developments and Future Plans
2.16 Iroko Pharmaceuticals
2.16.1 Iroko Pharmaceuticals Details
2.16.2 Iroko Pharmaceuticals Major Business
2.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions
2.16.4 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Iroko Pharmaceuticals Recent Developments and Future Plans
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business
2.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
2.17.4 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Hengrui Pharmaceutical Recent Developments and Future Plans
2.18 Abiogen Pharma
2.18.1 Abiogen Pharma Details
2.18.2 Abiogen Pharma Major Business
2.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions
2.18.4 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Abiogen Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drugs for Osteoarthritis Pain Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Drugs for Osteoarthritis Pain Players Market Share
3.2.2 Top 10 Drugs for Osteoarthritis Pain Players Market Share
3.2.3 Market Competition Trend
3.3 Drugs for Osteoarthritis Pain Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Drugs for Osteoarthritis Pain Revenue and Market Share by Type (2016-2021)
4.2 Global Drugs for Osteoarthritis Pain Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2016-2021)
5.2 Drugs for Osteoarthritis Pain Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Drugs for Osteoarthritis Pain Revenue by Type (2016-2026)
6.2 North America Drugs for Osteoarthritis Pain Revenue by Application (2016-2026)
6.3 North America Drugs for Osteoarthritis Pain Market Size by Country
6.3.1 North America Drugs for Osteoarthritis Pain Revenue by Country (2016-2026)
6.3.2 United States Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
6.3.3 Canada Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
6.3.4 Mexico Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Drugs for Osteoarthritis Pain Revenue by Type (2016-2026)
7.2 Europe Drugs for Osteoarthritis Pain Revenue by Application (2016-2026)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Country
7.3.1 Europe Drugs for Osteoarthritis Pain Revenue by Country (2016-2026)
7.3.2 Germany Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
7.3.3 France Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
7.3.5 Russia Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
7.3.6 Italy Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2016-2026)
8.2 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2016-2026)
8.3 Asia-Pacific Drugs for Osteoarthritis Pain Market Size by Region
8.3.1 Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2016-2026)
8.3.2 China Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
8.3.3 Japan Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
8.3.4 South Korea Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
8.3.5 India Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
8.3.7 Australia Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Drugs for Osteoarthritis Pain Revenue by Type (2016-2026)
9.2 South America Drugs for Osteoarthritis Pain Revenue by Application (2016-2026)
9.3 South America Drugs for Osteoarthritis Pain Market Size by Country
9.3.1 South America Drugs for Osteoarthritis Pain Revenue by Country (2016-2026)
9.3.2 Brazil Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
9.3.3 Argentina Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2016-2026)
10.2 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2016-2026)
10.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Country
10.3.1 Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2016-2026)
10.3.2 Turkey Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
10.3.4 UAE Drugs for Osteoarthritis Pain Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Drugs for Osteoarthritis Pain Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Drugs for Osteoarthritis Pain Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Region (2016-2021)
Table 5. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Drugs for Osteoarthritis Pain Product and Solutions
Table 9. Pfizer Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Drugs for Osteoarthritis Pain Product and Solutions
Table 13. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 15. GlaxoSmithKline Major Business
Table 16. GlaxoSmithKline Drugs for Osteoarthritis Pain Product and Solutions
Table 17. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bayer Corporate Information, Head Office, and Major Competitors
Table 19. Bayer Major Business
Table 20. Bayer Drugs for Osteoarthritis Pain Product and Solutions
Table 21. Bayer Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 23. Eli Lilly Major Business
Table 24. Eli Lilly Drugs for Osteoarthritis Pain Product and Solutions
Table 25. Eli Lilly Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Novartis Corporate Information, Head Office, and Major Competitors
Table 27. Novartis Major Business
Table 28. Novartis Drugs for Osteoarthritis Pain Product and Solutions
Table 29. Novartis Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Sanofi Corporate Information, Head Office, and Major Competitors
Table 31. Sanofi Major Business
Table 32. Sanofi Drugs for Osteoarthritis Pain Product and Solutions
Table 33. Sanofi Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Horizon Pharma Corporate Information, Head Office, and Major Competitors
Table 35. Horizon Pharma Major Business
Table 36. Horizon Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 37. Horizon Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Abbott Corporate Information, Head Office, and Major Competitors
Table 39. Abbott Major Business
Table 40. Abbott Drugs for Osteoarthritis Pain Product and Solutions
Table 41. Abbott Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Mylan Corporate Information, Head Office, and Major Competitors
Table 43. Mylan Major Business
Table 44. Mylan Drugs for Osteoarthritis Pain Product and Solutions
Table 45. Mylan Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 47. Daiichi Sankyo Major Business
Table 48. Daiichi Sankyo Drugs for Osteoarthritis Pain Product and Solutions
Table 49. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. TEVA Corporate Information, Head Office, and Major Competitors
Table 51. TEVA Major Business
Table 52. TEVA Drugs for Osteoarthritis Pain Product and Solutions
Table 53. TEVA Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Almatica Pharma Corporate Information, Head Office, and Major Competitors
Table 55. Almatica Pharma Major Business
Table 56. Almatica Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 57. Almatica Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Astellas Pharma Corporate Information, Head Office, and Major Competitors
Table 59. Astellas Pharma Major Business
Table 60. Astellas Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 61. Astellas Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Tide Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 63. Tide Pharmaceutical Major Business
Table 64. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
Table 65. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Iroko Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 67. Iroko Pharmaceuticals Major Business
Table 68. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product and Solutions
Table 69. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Hengrui Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 71. Hengrui Pharmaceutical Major Business
Table 72. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product and Solutions
Table 73. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Abiogen Pharma Corporate Information, Head Office, and Major Competitors
Table 75. Abiogen Pharma Major Business
Table 76. Abiogen Pharma Drugs for Osteoarthritis Pain Product and Solutions
Table 77. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Players (2019-2021)
Table 79. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2019-2021)
Table 80. Breakdown of Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Drugs for Osteoarthritis Pain Players Head Office, Products and Services Provided
Table 82. Drugs for Osteoarthritis Pain Mergers & Acquisitions in the Past Five Years
Table 83. Drugs for Osteoarthritis Pain New Entrants and Expansion Plans
Table 84. Global Drugs for Osteoarthritis Pain Revenue (USD Million) by Type (2016-2021)
Table 85. Global Drugs for Osteoarthritis Pain Revenue Share by Type (2016-2021)
Table 86. Global Drugs for Osteoarthritis Pain Revenue Forecast by Type (2021-2026)
Table 87. Global Drugs for Osteoarthritis Pain Revenue by Application (2016-2021)
Table 88. Global Drugs for Osteoarthritis Pain Revenue Forecast by Application (2021-2026)
Table 89. North America Drugs for Osteoarthritis Pain Revenue by Type (2016-2021) & (USD Million)
Table 90. North America Drugs for Osteoarthritis Pain Revenue by Type (2021-2026) & (USD Million)
Table 91. North America Drugs for Osteoarthritis Pain Revenue by Application (2016-2021) & (USD Million)
Table 92. North America Drugs for Osteoarthritis Pain Revenue by Application (2021-2026) & (USD Million)
Table 93. North America Drugs for Osteoarthritis Pain Revenue by Country (2016-2021) & (USD Million)
Table 94. North America Drugs for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 95. Europe Drugs for Osteoarthritis Pain Revenue by Type (2016-2021) & (USD Million)
Table 96. Europe Drugs for Osteoarthritis Pain Revenue by Type (2021-2026) & (USD Million)
Table 97. Europe Drugs for Osteoarthritis Pain Revenue by Application (2016-2021) & (USD Million)
Table 98. Europe Drugs for Osteoarthritis Pain Revenue by Application (2021-2026) & (USD Million)
Table 99. Europe Drugs for Osteoarthritis Pain Revenue by Country (2016-2021) & (USD Million)
Table 100. Europe Drugs for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 101. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2016-2021) & (USD Million)
Table 102. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2016-2021) & (USD Million)
Table 104. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2016-2021) & (USD Million)
Table 106. Asia-Pacific Drugs for Osteoarthritis Pain Revenue by Region (2021-2026) & (USD Million)
Table 107. South America Drugs for Osteoarthritis Pain Revenue by Type (2016-2021) & (USD Million)
Table 108. South America Drugs for Osteoarthritis Pain Revenue by Type (2021-2026) & (USD Million)
Table 109. South America Drugs for Osteoarthritis Pain Revenue by Application (2016-2021) & (USD Million)
Table 110. South America Drugs for Osteoarthritis Pain Revenue by Application (2021-2026) & (USD Million)
Table 111. South America Drugs for Osteoarthritis Pain Revenue by Country (2016-2021) & (USD Million)
Table 112. South America Drugs for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
Table 113. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2016-2021) & (USD Million)
Table 114. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2016-2021) & (USD Million)
Table 116. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2016-2021) & (USD Million)
Table 118. Middle East & Africa Drugs for Osteoarthritis Pain Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Picture
Figure 2. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Injection
Figure 5. External
Figure 6. Drugs for Osteoarthritis Pain Revenue Market Share by Application in 2020
Figure 7. Medical Care Picture
Figure 8. Personal Care Picture
Figure 9. Global Drugs for Osteoarthritis Pain Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Drugs for Osteoarthritis Pain Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region (2016-2026)
Figure 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Region in 2020
Figure 13. North America Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Drugs for Osteoarthritis Pain Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Drugs for Osteoarthritis Pain Market Drivers
Figure 19. Drugs for Osteoarthritis Pain Market Restraints
Figure 20. Drugs for Osteoarthritis Pain Market Trends
Figure 21. Pfizer Recent Developments and Future Plans
Figure 22. Johnson & Johnson Recent Developments and Future Plans
Figure 23. GlaxoSmithKline Recent Developments and Future Plans
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. Eli Lilly Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. Horizon Pharma Recent Developments and Future Plans
Figure 29. Abbott Recent Developments and Future Plans
Figure 30. Mylan Recent Developments and Future Plans
Figure 31. Daiichi Sankyo Recent Developments and Future Plans
Figure 32. TEVA Recent Developments and Future Plans
Figure 33. Almatica Pharma Recent Developments and Future Plans
Figure 34. Astellas Pharma Recent Developments and Future Plans
Figure 35. Tide Pharmaceutical Recent Developments and Future Plans
Figure 36. Iroko Pharmaceuticals Recent Developments and Future Plans
Figure 37. Hengrui Pharmaceutical Recent Developments and Future Plans
Figure 38. Abiogen Pharma Recent Developments and Future Plans
Figure 39. Global Drugs for Osteoarthritis Pain Revenue Share by Players in 2020
Figure 40. Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 41. Global Top 3 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2020
Figure 42. Global Top 10 Players Drugs for Osteoarthritis Pain Revenue Market Share in 2020
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 44. Global Drugs for Osteoarthritis Pain Revenue Share by Type in 2020
Figure 45. Global Drugs for Osteoarthritis Pain Market Share Forecast by Type (2021-2026)
Figure 46. Global Drugs for Osteoarthritis Pain Revenue Share by Application in 2020
Figure 47. Global Drugs for Osteoarthritis Pain Market Share Forecast by Application (2021-2026)
Figure 48. North America Drugs for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 49. North America Drugs for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 50. North America Drugs for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 51. United States Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Canada Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Mexico Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Europe Drugs for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 55. Europe Drugs for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 56. Europe Drugs for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 57. Germany Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. France Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. United Kingdom Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Russia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Italy Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 63. Asia-Pacific Drugs for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Drugs for Osteoarthritis Pain Revenue Market Share by Region (2016-2026)
Figure 65. China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South Korea Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. India Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Southeast Asia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Australia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. South America Drugs for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 72. South America Drugs for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 73. South America Drugs for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 74. Brazil Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Argentina Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Middle East and Africa Drugs for Osteoarthritis Pain Sales Market Share by Type (2016-2026)
Figure 77. Middle East and Africa Drugs for Osteoarthritis Pain Sales Market Share by Application (2016-2026)
Figure 78. Middle East and Africa Drugs for Osteoarthritis Pain Revenue Market Share by Country (2016-2026)
Figure 79. Turkey Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. UAE Drugs for Osteoarthritis Pain Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の変形性関節症治療薬市場 2021：企業別、地域別、種類・用途別 The Osteoarthritis Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…- 世界の変形性関節症治療市場 2021：企業別、地域別、種類・用途別 The Osteoarthritis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の変形性膝関節症粘液補充療法市場 2021：企業別、地域別、種類・用途別 The Viscosupplementation for Knee Osteoarthritis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の慢性膵炎疼痛市場 2021：企業別、地域別、種類・用途別 The Chronic Pancreatitis Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
- 世界の変形性関節症用ヒアルロン酸市場 2021：企業別、地域別、種類・用途別 The Hyaluronic Acid for Osteoarthritis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…